U.S. Markets open in 3 hrs 46 mins
  • S&P Futures

    4,268.25
    -18.25 (-0.43%)
     
  • Dow Futures

    33,878.00
    -103.00 (-0.30%)
     
  • Nasdaq Futures

    13,451.50
    -71.75 (-0.53%)
     
  • Russell 2000 Futures

    1,990.70
    -11.00 (-0.55%)
     
  • Crude Oil

    89.75
    -0.75 (-0.83%)
     
  • Gold

    1,767.40
    -3.80 (-0.21%)
     
  • Silver

    19.19
    -0.27 (-1.41%)
     
  • EUR/USD

    1.0095
    +0.0003 (+0.0303%)
     
  • 10-Yr Bond

    2.8800
    0.0000 (0.00%)
     
  • Vix

    20.11
    +0.21 (+1.06%)
     
  • GBP/USD

    1.1914
    -0.0019 (-0.1596%)
     
  • USD/JPY

    136.6400
    +0.7780 (+0.5726%)
     
  • BTC-USD

    21,787.41
    -1,701.67 (-7.24%)
     
  • CMC Crypto 200

    517.93
    -39.80 (-7.14%)
     
  • FTSE 100

    7,537.54
    -4.31 (-0.06%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

Gilead Sciences to Release Second Quarter 2022 Financial Results on Tuesday, August 2, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FOSTER CITY, Calif., July 12, 2022--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2022 financial results will be released on Tuesday, August 2, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s second quarter 2022 financial results and will provide a business update.

A live webcast will be available on the investor relations section of investors.gilead.com and will be archived there for one year.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220712006055/en/

Contacts

Jacquie Ross, Investors
investor_relations@gilead.com